Data as of Q4 2025 (Dec 31, 2025)

PFIZER INC

โ€ขCIK: 78003โ€ขFiling: Q4 2025

**PFIZER INC** manages $236M across 18 distinct positions, exhibiting a concentrated, sector-specific mandate. The portfolio is anchored by significant allocations to ORIC ($44.0M) and ARVN ($41.0M), representing the two largest holdings. Further substantial exposure is maintained in CELC ($34.8M) and BLK ($31.9M), suggesting deep conviction in specific pharmaceutical or biotech sub-sectors. This structure indicates a highly focused, large-cap healthcare investment thesis.

Total AUM
$236.5M
QoQ Performance
-45.9%
Positions
18
Top 10 Concentration
95.4%
Latest Filing
Q4 2025

Top Holdings Allocation

ORIC
ARVN
CELC
WVE
ALLO
ZURA
ORIC18.6%
ARVN17.3%
CELC14.7%
WVE13.5%
ALLO12.8%
ZURA6.6%
PYXS3.4%
CRBU3.2%

๐Ÿ“ˆ Biggest Buys

No new positions or increases this quarter

๐Ÿ“‰ Biggest Sells

SENS1GBP
SENSEONICS HLDGS INC
-95.0%
0.0% of portfolio

Sector Breakdown

Other100.0%

๐Ÿšช Exited Positionssold since Q3 2025

BNTX
BIONTECH SE
SOLD
$163.5M
โ€”
TOURMALINE BIO INC
SOLD
$60.8M
โ€”
ESSA PHARMA INC
SOLD
$319.9K

Changes from Q3 2025

โ†“1 decreased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024